GSA Capital Partners’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,320
| Closed | -$213K | – | 2012 |
|
|
2024
Q4 | $213K | Buy |
+7,320
| New | +$213K | 0.02% | 1383 |
|
|
2024
Q1 | – | Sell |
-144,202
| Closed | -$1.31M | – | 1914 |
|
|
2023
Q4 | $1.31M | Sell |
144,202
-195,477
| -58% | -$1.77M | 0.11% | 272 |
|
|
2023
Q3 | $2.17M | Buy |
339,679
+282,270
| +492% | +$1.8M | 0.19% | 91 |
|
|
2023
Q2 | $637K | Buy |
57,409
+26,747
| +87% | +$297K | 0.06% | 584 |
|
|
2023
Q1 | $471K | Sell |
30,662
-20,977
| -41% | -$322K | 0.05% | 752 |
|
|
2022
Q4 | $1.15M | Buy |
+51,639
| New | +$1.15M | 0.14% | 153 |
|